The findings from IBCSG studies are often incorporated into clinical practice guidelines and treatment recommendations. Organizations such as the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) frequently reference IBCSG research in their guidelines. By providing robust evidence on the safety and efficacy of different treatment options, the IBCSG helps oncologists make informed decisions about patient care.
